Building a Women’s Health Telehealth Brand for Perimenopause and Menopause (HRT) – What You Need to Know

• The perimenopause and menopause moment — why millions of women were told for decades to “push through” hot flashes, sleep disruption, mood instability, and cognitive fog, and why that's finally changing
• The market opportunity — 55M+ women in perimenopause or menopause in the U.S., a global market headed toward $24B+ by 2030, and why less than 25% of eligible women are currently on therapy
• What compliant BHRT actually requires — delivery routes, compounding pharmacy sourcing, and the clinical infrastructure operators need to launch responsibly
• Clinical considerations for operators — prescribing criteria, patient selection, monitoring cadence, and how to guide patients who've likely already been dismissed by at least one provider

Whether you're evaluating HRT for your program or trying to understand what it actually takes to serve this population well, this session will give you the clearest picture available right now.